首页> 外文期刊>Transplantation: Official Journal of the Transplantation Society >Lung preconditioning with N-acetyl-L-cysteine prevents reperfusion injury after liver no flow-reflow: a dose-response study.
【24h】

Lung preconditioning with N-acetyl-L-cysteine prevents reperfusion injury after liver no flow-reflow: a dose-response study.

机译:N-乙酰基-L-半胱氨酸对肺的预处理可防止肝脏无血流回流后的再灌注损伤:一项剂量反应研究。

获取原文
获取原文并翻译 | 示例
           

摘要

BACKGROUND: Circulating xanthine oxidase activity and the generated oxidants have been linked to lung reperfusion injury from no flow-reflow conditions in other organs after organ transplantation or surgery. N-acetyl-1-cysteine (NAC), an oxidant scavenger, promotes glutathione in its reduced form (GSH) that is depleted during ischemia. We have recently demonstrated its efficacy in protecting lungs from reperfusion injury if administered during reperfusion of postischemic liver. We now investigated whether preconditioning of lungs with NAC could attenuate lung respiratory or vascular derangement after no flow-reflow (ischemia-reperfusion, IR) and if this depends on lung GSH levels. METHODS: Rat isolated livers were stabilized and perfused with modified Krebs-Henseleit solution (KH) (control, n=12) or made ischemic (no flow, IR-0, n=12) for 2 hr. Meanwhile, lungs were isolated, ventilated, and stabilized (KH+bovine albumin 5%). Serial perfusion (15 min) of liver+lung pairs took place followed by lung only recirculation (45 min) with the accumulated solution. Another three controls and three ischemic groups included lungs treated during stabilization with NAC at 100 mg x kg(-1), 150 or 225 mg x kg(-1) (in 2.5, 3.7 or 5.5 mmol solutions, respectively). Results. Ischemic liver damage, expressed by circulating hepatocellular constituents, was associated with pulmonary artery and ventilatory pressure increases by 70-100% of baseline, abnormal wet-to-dry weight ratio, and abnormal bronchoalveolar lavage volume and content in the IR-0 (nontreated) and the IR-100 and IR-225 pretreated lungs. NAC-150 pretreatment afforded preservation for most parameters. GSH content in the IR-150 lung tissue was only 11% higher than that of IR-225, but 2-fold that in IR-0 and IR-100 GSH lungs. CONCLUSION: Lung preconditioning with NAC prevents reperfusion injury but not in a dose-related manner. Although enhanced GSH tissue content explains lung protection, GSH-independent NAC activity is another possibility.
机译:背景:循环黄嘌呤氧化酶活性和所产生的氧化剂与器官移植或手术后其他器官无血流回流条件引起的肺再灌注损伤有关。 N-乙酰基-1-半胱氨酸(NAC),一种氧化剂清除剂,可促进谷胱甘肽还原形式(GSH)的产生,这种形式在缺血期间会耗尽。我们最近证明,如果在缺血后肝脏的再灌注过程中施用,它可以保护肺免受再灌注损伤。现在,我们研究了在无血流回流(缺血-再灌注,IR)后,用NAC预处理肺是否可以减轻肺呼吸或血管紊乱,并且这是否取决于肺GSH水平。方法:将大鼠离体肝脏稳定并用改良的Krebs-Henseleit溶液(KH)灌注(对照组,n = 12)或使其缺血(无血流,IR-0,n = 12)2小时。同时,将肺分离,通风并稳定(KH +牛白蛋白5%)。进行肝+肺对的连续灌注(15分钟),然后仅用积累的溶液进行肺再循环(45分钟)。另外三个对照组和三个缺血组包括在用NAC稳定化期间分别以100 mg x kg(-1),150或225 mg x kg(-1)(分别在2.5、3.7或5.5 mmol溶液中)治疗的肺。结果。循环肝细胞成分表达的缺血性肝损伤与肺动脉和通气压力增加基线的70-100%,干湿重比异常,支气管肺泡灌洗量和IR-0含量异常有关(未经处理) )和IR-100和IR-225预处理的肺。 NAC-150预处理可以保留大多数参数。 IR-150肺组织中的GSH含量仅比IR-225高11%,但是IR-0和IR-100 GSH肺的2倍。结论:使用NAC进行肺预处理可预防再灌注损伤,但不能以剂量相关的方式进行。尽管增加的GSH组织含量可以说明对肺的保护,但另一种可能是不依赖GSH的NAC活性。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号